Mon, December 11, 2023

Jason Gerberry Maintained (BLUE) at Strong Buy with Increased Target to $12 on, Dec 11th, 2023

Jason Gerberry of B of A Securities, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Increased Target from $11 to $12 on, Dec 11th, 2023.

Jason has made no other calls on BLUE in the last 4 months.



There are 4 other peers that have a rating on BLUE. Out of the 4 peers that are also analyzing BLUE, 2 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeffrey Hung of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $7 on, Friday, December 8th, 2023
  • Eric Schmidt of "Cantor Fitzgerald" Initiated at Hold on, Tuesday, October 17th, 2023


These are the ratings of the 2 analyists that currently disagree with Jason


  • Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $13 on, Wednesday, November 8th, 2023
  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $4.21 on, Wednesday, September 6th, 2023